Pfizer Investors Eye Major Turnaround as Pharmaceutical Giant Rebuilds Its Growth Strategy
The narrative surrounding Pfizer has undergone a radical transformation over the last twenty-four months, shifting from the dizzying heights of global vaccine
by 
Josh Weiner
Josh Weiner